Clariane SE (EPA:CLARI)
France
· Delayed Price · Currency is EUR 3.854
+0.016 (0.42%)
At close: Mar 6, 2026
Clariane SE Revenue
In the year 2025, Clariane SE had annual revenue of 5.31B EUR with 0.54% growth. Clariane SE had revenue of 2.65B in the half year ending December 31, 2025, with 4.43% growth.
Revenue
5.31B
Revenue Growth
+0.54%
P/S Ratio
0.26
Revenue / Employee
85.93K
Employees
61,798
Market Cap
1.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.31B | 28.54M | 0.54% |
| Dec 31, 2024 | 5.28B | 286.17M | 5.73% |
| Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
| Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
| Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| emeis Société anonyme | 5.77B |
| Nanobiotix | 10.16M |
| Ramsay Générale de Santé | 5.32B |
| DBV Technologies | 4.69M |